Skip to main content

Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company headquartered in London, United Kingdom. The enterprise develops, manufactures, and markets a broad portfolio of generic, branded, and injectable medications. Its product divisions cover anti-infectives, central nervous system treatments, oncology medicines, respiratory products, and pain management therapeutics. Principal revenue is derived from direct pharmaceutical sales to hospitals, pharmacies, healthcare institutions, and wholesale distributors. The firm maintains commercial operations across the Middle East, North Africa, the United States, and Europe. Hikma Pharmaceuticals PLC is publicly traded on the London Stock Exchange.

27 of the funds FundTelligence covers report a position in Hikma Pharmaceuticals.

Legal name
Hikma Pharmaceuticals Plc
Sector
Health Care
Country
United Kingdom
Funds holding it
27

Funds holding Hikma Pharmaceuticals

Showing the 8 largest of 27 funds holding it.

Loading...